{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:02:23Z","timestamp":1786118543977,"version":"build-2736575974"},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anti-Cancer Drugs"],"published-print":{"date-parts":[[1990,12]]},"DOI":"10.1097\/00001813-199012000-00012","type":"journal-article","created":{"date-parts":[[2006,11,21]],"date-time":"2006-11-21T21:38:33Z","timestamp":1164145113000},"page":"187-208","source":"Crossref","is-referenced-by-count":4,"title":["Asbestos-related benign disease and cancer"],"prefix":"10.1097","volume":"1","author":[{"given":"Ulrich F","family":"Gruber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","container-title":["Anti-Cancer Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001813-199012000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:05:07Z","timestamp":1786032307000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001813-199012000-00012"}},"subtitle":["symptoms and treatment"],"short-title":[],"issued":{"date-parts":[[1990,12]]},"references-count":0,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1097\/00001813-199012000-00012","relation":{},"ISSN":["0959-4973"],"issn-type":[{"value":"0959-4973","type":"print"}],"subject":[],"published":{"date-parts":[[1990,12]]}}}